Clinical trials
Phase 2 Uterine Cervical Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 4 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 14 |
| 2022 | 12 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lei Li | 6 |
| Peking Union Medical College Hospital | 4 |
| Zhejiang Cancer Hospital | 3 |
| Chang Gung Memorial Hospital | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Hunan Cancer Hospital | 2 |
| Qilu Pharmaceutical Co., Ltd. | 2 |
| Tata Memorial Hospital | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| Women's Hospital School Of Medicine Zhejiang University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 76 |
| Ovarian Neoplasms | 9 |
| Endometrial Neoplasms | 8 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Ovarian Epithelial | 3 |
| Carcinoma, Renal Cell | 3 |
| Vaginal Neoplasms | 3 |
| Vulvar Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.